Elucidating the Neuroprotective Effect of Tecoma stans Leaf Extract in STZ-Induced Diabetic Neuropathy

Abstract

Background. Diabetes is considered one of the most encyclopedic metabolic disorders owing to an alarming rise in the number of patients, which is increasing at an exponential rate. With the current therapeutics, which only aims to provide symptomatic and momentary relief, the scientists are shifting gears to explore alternative therapies which not only can target diabetes but can also help in limiting the progression of diabetic complications including diabetic neuropathy (DN). Methods. Tecoma stans leaf methanolic extract was prepared using the Soxhlet method. A streptozotocin (STZ; 45 mg/kg)-induced diabetic animal model was used and treatment with oral dosing of T. stans leaf extract at the different doses of 200 mg/kg, 300 mg/kg, and highest dose, i.e., 400 mg/kg, was initiated on day 3 after STZ administration. The pharmacological response for general and biochemical (angiogenic, inflammatory, and oxidative) parameters and behavioral parameters were compared using Gabapentin as a standard drug with the results from the test drug. Results. Parameters associated with the pathogenesis of diabetic neuropathy were evaluated. For general parameters, different doses of T. stans extract (TSE) on blood sugar showed significant effects as compared to the diabetic group. Also, the results from biochemical analysis and behavioral parameters showed significant positive effects in line with general parameters. The combination therapy of TSE at 400 mg/kg with a standard drug produced nonsignificant effects in comparison with the normal group. Conclusion. The leaves of T. stans possess antidiabetic effects along with promising effects in the management of DN by producing significant effects by exhibiting antioxidative, antiangiogenic, and anti-inflammatory properties, which are prognostic markers for DN, and thus, T. stans can be considered as an emerging therapeutic option for DN.

Effects of Taraxerol on Oxidative and Inflammatory Mediators in Isoproterenol-Induced Cardiotoxicity in an Animal Model

“…ISO causes lesions in animals similar to those caused by myocardial infarction by acting on adrenergic receptors. These receptors stimulate intracellular calcium influx, which raises cAMP levels and depletes high-energy phosphates [ 44 , 45 ]. These lesions have a morphological appearance comparable to myofibrillar degeneration, cardiac enlargement, myocyte destruction, and cardiomyopathy [ 46 ], including MI.…”

Chiranthodendron pentadactylon Larreat (Sterculiaceae), a Potential Nephroprotector against Oxidative Damage Provoked by STZ-Induced Hyperglycemia in Rats

“…Nevertheless, it is essential to evaluate specific biomarkers of inflammation to elucidate this issue. Although it is known that the STZ model is used to experimentally emulate diabetes, in the search for new hypoglycemic agents, previous work has described the use of the model to evaluate the antioxidant activity of new molecules against OS associated with these chronic degenerative diseases, and its adverse sequelae, and how biological systems such as neuronal and renal are affected [36][37][38][39].…”

Effects of Various Herbal leaves Extract and Their Phytoconstituents in the Cure of Diabetic Nephropathy by ‘Streptozotocin-induced in Rats’ Model - A Review

“…The primary bioactive elements that contribute to its medicinal advantages are alkaloids, phenolic acids, flavonoids, and fatty acids 41 . Understanding Tecoma stans leaf extract's neuroprotective role in STZ-induced DN and observing the disease's effectiveness and improvements as well as the drop in MDA levels 52 .…”